Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (191-200 of 587) with videos related to

Pageof 59
Sort By:
Neurotoxicology|December 31, 2003
Monoamine oxidase inhibition and CNS immunodeficiency infectionE Koutsilieri, C Scheller, V ter Meulen, et al.
Arzneimittel-Forschung|February 1, 1992
Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophreniaP Riederer, K W Lange, J Kornhuber, et al.
Neuropharmacology|December 1, 1981
Dopamine receptors and schizophrenia: the neuroleptic drug problemG P Reynolds, P Riederer, K Jellinger, et al.
Brain Research|August 5, 1998
Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's diseaseG Münch, A M Cunningham, P Riederer, et al.
European Journal of Pharmacology|December 12, 1991
MPTP mechanisms of neurotoxicity and their implications for Parkinson's diseaseM Gerlach, P Riederer, H Przuntek, et al.
Journal of Neural Transmission. Supplementum|January 1, 1991
Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosisP Riederer, K W Lange, J Kornhuber, et al.
Journal of Neural Transmission. Supplementum|January 1, 1978
Brain monoamines in hepatic encephalopathy and other types of metabolic comaK Jellinger, P Riederer, W D Rausch, et al.
Infection|November 1, 1996
High prevalence of opportunistic infections in the head and neck related to human immunodeficiency virus. A prospective study of the distribution of otorhinolaryngologic disorders in 250 patientsA P Riederer, G O Grein, J R Bogner
Journal of Neural Transmission. Supplementum|January 1, 1995
Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?D Blum-Degen, L Frölich, S Hoyer, et al.
Journal of Neural Transmission. Supplementum|January 1, 1996
New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegilineM Gerlach, H Desser, M B Youdim, et al.
Pageof 59

Showing results (191-200 of 587) with videos related to

Sort By:
Pageof 59
Neurotoxicology|December 31, 2003
Monoamine oxidase inhibition and CNS immunodeficiency infectionE Koutsilieri, C Scheller, V ter Meulen, et al.
Arzneimittel-Forschung|February 1, 1992
Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophreniaP Riederer, K W Lange, J Kornhuber, et al.
Neuropharmacology|December 1, 1981
Dopamine receptors and schizophrenia: the neuroleptic drug problemG P Reynolds, P Riederer, K Jellinger, et al.
Brain Research|August 5, 1998
Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's diseaseG Münch, A M Cunningham, P Riederer, et al.
European Journal of Pharmacology|December 12, 1991
MPTP mechanisms of neurotoxicity and their implications for Parkinson's diseaseM Gerlach, P Riederer, H Przuntek, et al.
Journal of Neural Transmission. Supplementum|January 1, 1991
Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosisP Riederer, K W Lange, J Kornhuber, et al.
Journal of Neural Transmission. Supplementum|January 1, 1978
Brain monoamines in hepatic encephalopathy and other types of metabolic comaK Jellinger, P Riederer, W D Rausch, et al.
Infection|November 1, 1996
High prevalence of opportunistic infections in the head and neck related to human immunodeficiency virus. A prospective study of the distribution of otorhinolaryngologic disorders in 250 patientsA P Riederer, G O Grein, J R Bogner
Journal of Neural Transmission. Supplementum|January 1, 1995
Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?D Blum-Degen, L Frölich, S Hoyer, et al.
Journal of Neural Transmission. Supplementum|January 1, 1996
New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegilineM Gerlach, H Desser, M B Youdim, et al.
Pageof 59